Clinical Trials Browser

Completed × Costs and Cost Analysis × 90 days × Clear all

NCT04319237 2026-03-02

Axicabtagene Ciloleucel:Neurocognitive and Patient-Reported Outcomes

Lymphoma, Large B-Cell, Diffuse